Sign in Subscribe
Biotechnology industries

Cyntellect, Inc. Appoints Experienced Biotech Executive Tina S. Nova to Board of Directors

Strategic Insights

— 1 min read

Tina S. Nova, a distinguished biotechnology executive, has joined the board of directors at Cyntellect, Inc., a privately held biotechnology company. Nova brings to the table extensive knowledge and experience in operational development, strategic planning, and executive management. Her unique blend of scientific expertise, strategic planning, operations expertise, and fundraising skills will be invaluable to Cyntellect as it expands its commercial operations. Nova has a proven track record as the president, CEO, and cofounder of Genoptix, and has held various leadership positions at other notable biotechnology companies.

Key Takeaways:

  • Tina S. Nova, PhD, has been appointed to the board of directors at Cyntellect, Inc., a privately held biotechnology company.
  • Nova brings extensive knowledge and experience in operational development, strategic planning, and executive management to Cyntellect.
  • She has a unique blend of scientific expertise, strategic planning, operations expertise, and fundraising skills, which will be valuable to the company as it expands its commercial operations.
  • Nova has a proven track record as the president, CEO, and cofounder of Genoptix, and has held leadership positions at other notable biotechnology companies, including Nanogen and Selective Genetics.
  • Nova's expertise will be instrumental in driving Cyntellect's growth and expansion in the biotechnology industry.
  • Nova holds a PhD in biochemistry from the University of California, Riverside, and conducted postdoctoral research at New York University Medical School.

Statistics:

  • Cyntellect, Inc. is a privately held biotechnology company.
  • Tina S. Nova has over 20 years of experience in the biotechnology industry.
  • Nova has served as president, CEO, and cofounder of Genoptix, a biotechnology company.
  • Nova has founded or cofounded several other biotechnology companies, including Nanogen and Selective Genetics.
  • Nova holds a PhD in biochemistry from the University of California, Riverside.
  • Nova conducted postdoctoral research at New York University Medical School.

Sources:

  • "Cyntellect, Inc. Appoints Experienced Biotech Executive Tina S. Nova to Board of Directors," Health & Medicine Week, 2005.
  • "Tina S. Nova, PhD, Joins Cyntellect, Inc. Board of Directors," NewsRx.com, 2005.
  • "Cyntellect, Inc. Press Release: Tina S. Nova Appointed to Board of Directors," NewsRx.net, 2005.
  • University of California, Riverside. "Tina S. Nova, PhD," (Biochemistry Department).
  • New York University Medical School. "Tina S. Nova, PhD," (Postdoctoral Researcher).

Read more